Zika Virus Testing Market 2027 By Type, End User | The Insight Partners

Zika Virus Testing Market to 2027 - Global Analysis and Forecasts by Type (Nucleic Acid Amplification Testing, Serological Testing); End User (Hospitals and Clinics, Private commercial labs, Government funded Programs)

Report Code: TIPRE00005566 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Zika Virus, a mosquito borne disease mainly affects the pregnant women and their fetus. Though there are no particular vaccine developed against the virus, the treatment prevails for cure of the affect since ages.

MARKET DYNAMICS
The Zika Virus Testing market is anticipated to grow in the forecast, owing to the factors such as emergency approval of POCT testing, increasing prevalence of Zika Virus affected disease, lack of awareness about the virus in several developing countries, increasing government funding and increasing medical tourism.

MARKET SCOPE
The "Global Zika Virus Testing Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Zika Virus Testing market with detailed market segmentation by type, end user and geography. The global Zika Virus Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Zika Virus Testing market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Zika Virus Testing market is segmented on the basis of type and end user. Based on type the market is segmented into Nucleic Acid Amplification Testing, Serological Testing. Based on end user the market is segmented into Hospitals and Clinics, Private commercial labs, Government funded Programs.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Zika Virus Testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Zika Virus Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Zika Virus Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Zika Virus Testing market in these regions.

MARKET PLAYERS
The reports cover key developments in the Zika Virus Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Zika Virus Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Zika Virus Testing market in the global market. Below mentioned is the list of few companies engaged in the Zika Virus Testing market.

The report also includes the profiles of Zika Virus Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Luminex Corporation
  • NecLife
  • Biocan Diagnostics Inc.
  • LumiQuick Diagnostics, Inc
  • JAJ International, Inc
  • GenBody Inc
  • RapiGEN Inc
  • Artron Laboratories Inc
  • Quest Diagnostics
  • Creative Diagnostics
  • EUROIMMUN US, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Zika Virus Testing Market - By Type
1.3.2 Zika Virus Testing Market - By End User
1.3.3 Zika Virus Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ZIKA VIRUS TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ZIKA VIRUS TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ZIKA VIRUS TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. ZIKA VIRUS TESTING - GLOBAL MARKET OVERVIEW
6.2. ZIKA VIRUS TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ZIKA VIRUS TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. NUCLEIC ACID AMPLIFICATION TESTING
7.3.1. Overview
7.3.2. Nucleic Acid Amplification Testing Market Forecast and Analysis
7.4. SEROLOGICAL TESTING
7.4.1. Overview
7.4.2. Serological Testing Market Forecast and Analysis
8. ZIKA VIRUS TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS AND CLINICS
8.3.1. Overview
8.3.2. Hospitals and Clinics Market Forecast and Analysis
8.4. PRIVATE COMMERCIAL LABS
8.4.1. Overview
8.4.2. Private commercial labs Market Forecast and Analysis
8.5. GOVERNMENT FUNDED PROGRAMS
8.5.1. Overview
8.5.2. Government funded Programs Market Forecast and Analysis
9. ZIKA VIRUS TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Zika Virus Testing Market Overview
9.1.2 North America Zika Virus Testing Market Forecasts and Analysis
9.1.3 North America Zika Virus Testing Market Forecasts and Analysis - By Type
9.1.4 North America Zika Virus Testing Market Forecasts and Analysis - By End User
9.1.5 North America Zika Virus Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Zika Virus Testing Market
9.1.5.1.1 United States Zika Virus Testing Market by Type
9.1.5.1.2 United States Zika Virus Testing Market by End User
9.1.5.2 Canada Zika Virus Testing Market
9.1.5.2.1 Canada Zika Virus Testing Market by Type
9.1.5.2.2 Canada Zika Virus Testing Market by End User
9.1.5.3 Mexico Zika Virus Testing Market
9.1.5.3.1 Mexico Zika Virus Testing Market by Type
9.1.5.3.2 Mexico Zika Virus Testing Market by End User
9.2. EUROPE
9.2.1 Europe Zika Virus Testing Market Overview
9.2.2 Europe Zika Virus Testing Market Forecasts and Analysis
9.2.3 Europe Zika Virus Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Zika Virus Testing Market Forecasts and Analysis - By End User
9.2.5 Europe Zika Virus Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Zika Virus Testing Market
9.2.5.1.1 Germany Zika Virus Testing Market by Type
9.2.5.1.2 Germany Zika Virus Testing Market by End User
9.2.5.2 France Zika Virus Testing Market
9.2.5.2.1 France Zika Virus Testing Market by Type
9.2.5.2.2 France Zika Virus Testing Market by End User
9.2.5.3 Italy Zika Virus Testing Market
9.2.5.3.1 Italy Zika Virus Testing Market by Type
9.2.5.3.2 Italy Zika Virus Testing Market by End User
9.2.5.4 Spain Zika Virus Testing Market
9.2.5.4.1 Spain Zika Virus Testing Market by Type
9.2.5.4.2 Spain Zika Virus Testing Market by End User
9.2.5.5 United Kingdom Zika Virus Testing Market
9.2.5.5.1 United Kingdom Zika Virus Testing Market by Type
9.2.5.5.2 United Kingdom Zika Virus Testing Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Zika Virus Testing Market Overview
9.3.2 Asia-Pacific Zika Virus Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Zika Virus Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Zika Virus Testing Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Zika Virus Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Zika Virus Testing Market
9.3.5.1.1 Australia Zika Virus Testing Market by Type
9.3.5.1.2 Australia Zika Virus Testing Market by End User
9.3.5.2 China Zika Virus Testing Market
9.3.5.2.1 China Zika Virus Testing Market by Type
9.3.5.2.2 China Zika Virus Testing Market by End User
9.3.5.3 India Zika Virus Testing Market
9.3.5.3.1 India Zika Virus Testing Market by Type
9.3.5.3.2 India Zika Virus Testing Market by End User
9.3.5.4 Japan Zika Virus Testing Market
9.3.5.4.1 Japan Zika Virus Testing Market by Type
9.3.5.4.2 Japan Zika Virus Testing Market by End User
9.3.5.5 South Korea Zika Virus Testing Market
9.3.5.5.1 South Korea Zika Virus Testing Market by Type
9.3.5.5.2 South Korea Zika Virus Testing Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Zika Virus Testing Market Overview
9.4.2 Middle East and Africa Zika Virus Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Zika Virus Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Zika Virus Testing Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Zika Virus Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Zika Virus Testing Market
9.4.5.1.1 South Africa Zika Virus Testing Market by Type
9.4.5.1.2 South Africa Zika Virus Testing Market by End User
9.4.5.2 Saudi Arabia Zika Virus Testing Market
9.4.5.2.1 Saudi Arabia Zika Virus Testing Market by Type
9.4.5.2.2 Saudi Arabia Zika Virus Testing Market by End User
9.4.5.3 U.A.E Zika Virus Testing Market
9.4.5.3.1 U.A.E Zika Virus Testing Market by Type
9.4.5.3.2 U.A.E Zika Virus Testing Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Zika Virus Testing Market Overview
9.5.2 South and Central America Zika Virus Testing Market Forecasts and Analysis
9.5.3 South and Central America Zika Virus Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Zika Virus Testing Market Forecasts and Analysis - By End User
9.5.5 South and Central America Zika Virus Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Zika Virus Testing Market
9.5.5.1.1 Brazil Zika Virus Testing Market by Type
9.5.5.1.2 Brazil Zika Virus Testing Market by End User
9.5.5.2 Argentina Zika Virus Testing Market
9.5.5.2.1 Argentina Zika Virus Testing Market by Type
9.5.5.2.2 Argentina Zika Virus Testing Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ZIKA VIRUS TESTING MARKET, KEY COMPANY PROFILES
11.1. LUMINEX CORPORATION
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. NECLIFE
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOCAN DIAGNOSTICS INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LUMIQUICK DIAGNOSTICS, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JAJ INTERNATIONAL, INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GENBODY INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. RAPIGEN INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ARTRON LABORATORIES INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. QUEST DIAGNOSTICS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. CREATIVE DIAGNOSTICS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
11.11. EUROIMMUN US, INC.
11.11.1. Key Facts
11.11.2. Business Description
11.11.3. Products and Services
11.11.4. Financial Overview
11.11.5. SWOT Analysis
11.11.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2.
The List of Companies

- Luminex Corporation
- NecLife
- Biocan Diagnostics Inc.
- LumiQuick Diagnostics, Inc
- JAJ International, Inc
- GenBody Inc
- RapiGEN Inc
- Artron Laboratories Inc
- Quest Diagnostics
- Creative Diagnostics
- EUROIMMUN US, Inc.